Eargo Inc. (EAR): Price and Financial Metrics
GET POWR RATINGS... FREE!
EAR Stock Price Chart Interactive Chart >
EAR Price/Volume Stats
| Current price | $0.97 | 52-week high | $40.21 |
| Prev. close | $1.05 | 52-week low | $0.95 |
| Day low | $0.95 | Volume | 1,478,500 |
| Day high | $1.06 | Avg. volume | 2,172,184 |
| 50-day MA | $1.98 | Dividend yield | N/A |
| 200-day MA | $5.40 | Market Cap | 38.26M |
Eargo Inc. (EAR) Company Bio
Eargo, Inc. develops next generation hearing aids and headsets solutions. It offers Eargomax, a new chip for maximum audio fidelity and noise reduction and Eargoplus a superior hearing technology designed for first time hearing aid users. The company was founded by Florent Michel, Raphael Michel and Daniel Shen on November 12, 2010 and is headquartered in San Jose, CA.
Latest EAR News From Around the Web
Below are the latest news stories about Eargo Inc that investors may wish to consider to help them evaluate EAR as an investment opportunity.
Volatility Of Eargo Inc. (EAR) Reaches 7.56%: Make Sure To Keep Your Seat Tight!Eargo Inc. (NASDAQ:EAR) concluded the trading at $5.07 on Friday, February 04 with a rise of 5.19% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $4.82 with its price kept floating in the range of $4.77 and $5.15 on the day. … Volatility Of Eargo Inc. (EAR) Reaches 7.56%: Make Sure To Keep Your Seat Tight! Read More » |
Eargo Applauds Proposed Rule for OTC Hearing Aids and Submits Public Comments to FDASAN JOSE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ: EAR ), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the submission of public comments to the Food and Drug Administration (FDA) concerning its proposed rule to create a new regulatory category of over the counter (OTC) hearing aids. Eargo is supportive of the FDA''s proposed rule and applauds the FDA''s efforts to broaden consumer access to hearing technology. Historically, most people with hearing loss who would benefit from wearing a hearing aid have never used them, even though unaddressed hearing loss is associated with significant negative health outcomes and increased costs. 1 , 2 Eargo believes the FDA''s efforts to establish a regulatory f... |
BBBY Stock Alert: Why Bed Bath & Beyond Is the No. 1 Trending Ticker TodayBed Bath & Beyond (BBBY) stock is on the rise today as the shares trend following the release of its fiscal Q3 2021 earnings report. |
EAR Stock: The DOJ News That Has Eargo Investors Hearing ‘Cha-Ching!’ TodayEargo (EAR) stock is rocketing higher on Thursday thanks to news from the DOJ concerning an investigation into the company. |
Eargos new hearing aids can automatically adjust to your environmentEargo has been making smart hearing aids for a while, but its sixth-generation device adds automatic sound adjustment depending on a users environment. It comes at a time where more companies are investing in sound boosting tech and the FDA has proposed a rule to establish a new over-the-counter hearing aid category to make the devices more accessible. |
EAR Price Returns
| 1-mo | N/A |
| 3-mo | -81.66% |
| 6-mo | -80.98% |
| 1-year | -97.56% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -80.98% |
| 2021 | -88.62% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...